HCPCS Code J7187: Humate-P billing, units, and Medicare coverage

Key takeaways

HCPCS Code J7187 describes injection of von Willebrand factor complex (Humate-P) per IU VWF:RCo. It bills Humate-P infusions in physician offices and outpatient settings.

Quantity billed is not the raw IU count. Divide the IU VWF:RCo administered by 100 and round to the nearest whole number. A 1,500 IU dose is reported as 15 units.

Primary ICD-10-CM diagnoses accepted with J7187 include D68.0 (von Willebrand disease) and D66 (hereditary factor VIII deficiency).

Humate-P is supplied in single-dose containers, so the drug line needs a JZ modifier when nothing is discarded and JW when some is.

Practice management software like Pabau supports J7187 billing workflows, from drug inventory tracking through to claim submission.

HCPCS Code J7187 is the billing code for Humate-P, a plasma-derived clotting factor concentrate used to treat von Willebrand disease (VWD) and hemophilia A.

Unlike most drug codes, J7187 is measured in international units of ristocetin cofactor activity, written IU VWF:RCo. That figure gets converted before it reaches the claim. Divide the IU administered by 100, then round to the nearest whole number.

The rest of this guide covers the descriptor, the unit math, the ICD-10 crosswalk, Medicare reimbursement, documentation, common errors, and related codes. It assumes you already know the medical billing basics and want the J7187 specifics.

HCPCS Code J7187: Full descriptor and code details

HCPCS Code J7187 sits in the J-series of HCPCS Level II codes. CMS maintains that series for drugs and biologicals administered other than by the oral method. The complete official descriptor is:

Humate-P is a plasma-derived concentrate containing both von Willebrand factor and Factor VIII. It is indicated to treat and prevent bleeding in adults with VWD.

It also treats hemophilia A when recombinant products are not appropriate. J7187 applies specifically to Humate-P branded product. Other VWF or factor VIII products use separate J-codes.

How to calculate J7187 billing units

Two meanings of the word “unit” collide on a J7187 claim. The descriptor is written per IU VWF:RCo, which suggests the claim carries the raw international unit count. Medicare converts the dose into billing units first.

The instruction is consistent across contractors. Palmetto GBA, First Coast in Jurisdiction N, and the underlying CMS hemophilia billing guidelines all give one formula. Divide the number of IU administered by 100, then round to the nearest whole number. That result is the quantity billed.

The rounding convention is spelled out rather than left to judgment:

• A fraction of .50 to .99 adds one billing unit, so 7.50 becomes 8
• A fraction of .01 to .49 adds nothing, so 12.40 becomes 12
• The rule covers roughly 30 hemophilia factor J-codes, J7187 among them, for physicians and Ambulatory Surgical Centers
• J7199, the not-otherwise-classified code, is the exception, with quantity billed always 1 plus supporting documentation

One more limit catches high-dose infusions. Palmetto GBA allows a maximum of 700 units on a single detail line for J7187, which is 70,000 IU. Anything larger has to be split across detail lines.

The IU figure you feed into the formula must match the infusion record exactly. If the vial label states 1,000 IU VWF:RCo and only 750 IU were administered, convert the 750, not the 1,000.

That gives 7.50, which rounds up to 8 billing units. The discarded remainder is reported on its own line rather than folded into that figure.

CMS lists Humate-P among the drugs supplied in single-dose containers, so the wastage modifiers apply. Report any discarded amount on a separate line with the JW modifier. When nothing is discarded, append JZ to the drug line to attest to it. Both requirements come from the CMS discarded drugs policy.

The diagram below traces one drug line end to end, from the infusion record through rounding to the wastage modifier.

ICD-10-CM diagnosis codes linked to J7187

Every J7187 claim needs a supporting ICD-10-CM diagnosis code that establishes medical necessity. The two primary diagnoses are stable in the 2026 code set, though coders should verify annually against the CMS ICD-10-CM update files.

Payer-specific policies may accept additional diagnosis codes, for example codes indicating hemorrhagic events or surgical prophylaxis.

Always confirm the accepted diagnosis list with your MAC’s Local Coverage Determination before submitting. An unsupported ICD-10 code on a J7187 claim is a common denial reason, and solid medical billing compliance processes prevent it.

Medicare coverage and reimbursement for J7187

Medicare Part B covers Humate-P under the buy-and-bill model for physician offices and outpatient hospital settings. Coverage is subject to medical necessity, so the clinical record must support both the diagnosis and the frequency of infusions.

Payment then moves through the same revenue cycle as any other Part B claim. Eligibility checks, unit accuracy, and denial follow-up all decide how fast the money lands.

2026 ASP pricing and fee schedule for J7187

Medicare reimburses J7187 under the Average Sales Price (ASP) plus 6% methodology. CMS updates ASP pricing quarterly, so any per-unit dollar figure quoted in a third-party publication may already be out of date.

Always verify the current quarter’s ASP rate before you bill. Use the CMS Physician Fee Schedule lookup tool or the quarterly ASP drug pricing files on cms.gov.

What stays consistent is the arithmetic. Payment applies the ASP+6% formula to each unit reported. Because one billing unit stands for 100 IU, a single-unit slip moves the payment by 100 IU worth of product. On high-dose VWD infusions, those slips add up fast.

MAC variation and Local Coverage Determinations

Medicare Administrative Contractors can impose coverage criteria beyond the national baseline. Palmetto GBA, for example, publishes dated unit submission guidance for hemophilia clotting factor J-codes, most recently updated in January 2026.

Other MACs such as Novitas and CGS may set different documentation requirements or prior authorization thresholds. Check your own MAC’s LCD before assuming the national rules apply uniformly.

Buy-and-bill model for Humate-P: Step-by-step process

Physician offices and outpatient hospital departments billing J7187 buy Humate-P directly from a specialty distributor. They administer it to the patient, then bill the payer for the drug plus the administration service.

Effective drug inventory management is essential here, because NDC tracking errors during buy-and-bill are a primary denial driver.

1. Acquire product: Order Humate-P from a licensed specialty distributor. Record the NDC number and lot number for every vial received. These are required on the claim.
2. Verify eligibility and prior authorization: Confirm the patient’s benefit plan covers J7187. Then check whether your MAC or commercial payer requires prior authorization for factor products.
3. Administer and document: Infuse the ordered dose and document the exact IU VWF:RCo administered in the treatment record. Include the lot number, NDC, dose, start time, stop time, and any adverse reactions.
4. Calculate units: Divide the administered IU VWF:RCo by 100 and round to the nearest whole number. If 1,250 IU were infused, the math gives 12.50, so the quantity billed is 13.
5. Bill the drug separately from administration: J7187 covers the drug only. Bill the infusion administration service using the appropriate CPT code, typically 96413 for the initial hour and 96415 for additional hours.
6. Include NDC on the claim: Buy-and-bill claims for physician-administered drugs need the 11-digit NDC in the right field. On 837P electronic claims, that is Loop 2410, LIN segment.

Documentation requirements for J7187 claims

Incomplete documentation is the second most common reason J7187 claims are denied or flagged for audit. Digital intake forms and structured treatment records cut the work of assembling all of it at claim time. Here is the full checklist:

• Infusion record: Documents the dose ordered, dose administered (exact IU VWF:RCo), route, rate, start and stop times, and clinician signature
• NDC number: 11-digit National Drug Code for the specific Humate-P lot administered
• Lot number: Required by most MACs, tied to the infusion record and the vial label
• Diagnosis codes: ICD-10-CM code(s) supporting medical necessity, with D68.0 or D66 as primary
• Wastage record: The discarded amount from an opened single-dose vial, supporting the JW line or the JZ attestation
• Medical necessity letter or prior authorization: Required by many MACs and commercial payers for ongoing factor replacement therapy
• Physician order: Signed order specifying the product, dose, and frequency
• Laboratory documentation: VWF:RCo activity levels or factor VIII assay results supporting the clinical indication

A well-constructed superbill that captures these elements at the point of care saves significant rework later. Build the checklist into the infusion workflow instead of reassembling it when the claim is due.

Common J7187 billing errors and how to avoid them

Palmetto GBA’s 2026 hemophilia factor guidance names a consistent set of errors across J7187 claims. Each one is preventable with the right workflow controls, and strong denial management starts by catching them before submission.

Related HCPCS codes for hemophilia factor products

HCPCS Code J7187 is specific to Humate-P. Other von Willebrand and factor VIII products carry their own J-codes. The plasma-derived and recombinant families do not overlap.

Selecting the wrong code is a non-billable service error. Use this reference table to keep J7187 apart from the codes closest to it.

Billing J7183 when Humate-P was administered will not always trigger an immediate technical denial. It is still inaccurate coding, and it invites post-payment recoupment once an auditor compares the product to the billed code. Match the J-code to the product dispensed every time.

The unit definitions above are descriptor language. Every code in this table sits on the same hemophilia factor list, so the divide-by-100 quantity rule holds when you switch codes.

Outside that list the descriptor sets the unit, and the divisor changes with it. J3470 counts up to 150 units of hyaluronidase as a single billing unit. Codes are also retired and crosswalked, as J3487 was, so re-read the descriptors each January.

How Pabau supports hemophilia infusion billing

Infusion practices billing J7187 run a documentation-heavy workflow. Lot numbers, NDC codes, exact IU counts, lab values, and physician orders all have to reach the claim intact. In many practices that means a scheduler, a paper infusion log, and a separate billing tool.

Practice management software like Pabau keeps those fields in one client record instead. Practices running an EMR built for infusion capture infusion detail in structured templates rather than free-text notes. Drug, dose, lot, NDC, route, and duration each get their own field, so unit extraction reads a number instead of a sentence.

Pabau’s claims management software then carries that record into the claim, and our Claim.MD integration submits it electronically. Nobody retypes the administered units, which is where the hundredfold errors start.

The same setup serves practices well beyond hematology. IV therapy practices and functional medicine practices buy and bill drugs on the same terms, and they need the same lot-level trail.

Specific Pabau capabilities relevant to J7187 billing workflows:

• Treatment records: Structured infusion templates capture IU VWF:RCo administered, lot number, and NDC at the point of care
• Drug inventory tracking: Log vial receipt, NDC, and lot number on arrival, then reconcile against administered doses at claim time
• Digital documentation: Lab values, physician orders, and medical necessity letters stored against the client record and retrievable for an audit
• Billing integration: Treatment records feed the billing workflow, so administered units are never re-entered by hand

Streamline your infusion billing workflow

Pabau helps infusion practices capture exact treatment documentation, track drug inventory by NDC and lot number, and submit cleaner claims with fewer denials. See how it works for hemophilia and specialty drug billing.

Book a demo

Conclusion

Two habits keep J7187 claims clean. Convert every dose from the infusion record rather than the vial label, and get your own MAC’s divisor and per-line maximum in writing.

Practices that build the conversion into the documentation template stop re-checking arithmetic at claim time. The check happens once, at the point of care, while the IU figure is still in front of the person who measured it.

The trade-off is worth naming. Structured infusion fields take a little longer to fill in than a free-text note. They are also what stands up when an auditor asks for the lot number two years later. Book a demo to see how Pabau links infusion records to the claim for VWD and hemophilia A programs.

Continue your research

Need guidance on IV therapy clinic operations? Opening an IV therapy clinic covers licensing, staffing, and operational requirements for infusion-based practices.

Looking to understand HIPAA requirements for your billing data? HIPAA compliance for medical offices outlines the safeguards needed for protected health information in billing workflows.

Billing another injectable drug code? J3470 walks through unit conversion and documentation for hyaluronidase injections.

Chasing a J-code that no longer pays? J3487 shows how a deleted code is crosswalked to its replacement without losing the claim.

Billing supplies alongside drugs? A4618 sets out how supply codes are documented and reported for 2026.

Frequently asked questions

Modifiers, documentation, and related codes